Literature DB >> 2807017

Incidence of malignant fallopian tube tumors.

K A Rosenblatt1, N S Weiss, S M Schwartz.   

Abstract

Incidence rates were examined for epithelial malignant fallopian tube neoplasms diagnosed between 1973 and 1984 and reported to nine population-based cancer registries in the United States. The average annual incidence was 3.6 per million women per year and there was no evidence of a change in the rate during the study period. Age-specific incidence followed a pattern similar to that observed for ovarian and endometrial neoplasms, rising rapidly during the reproductive years and flattening out thereafter. The incidence rate varied only slightly by race, with whites having a higher rate than blacks. Considerable variation in incidence was observed among the registries. While this could have been due to true regional differences in incidence, we cannot rule out the possibility that misclassification of fallopian tube tumors as ovarian tumors was responsible. Further investigations into the etiology of fallopian tube neoplasms should focus on the role of reproductive factors that have previously been reported as risk factors for ovarian and endometrial neoplasms.

Entities:  

Mesh:

Year:  1989        PMID: 2807017     DOI: 10.1016/0090-8258(89)90051-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Cancer-associated retinopathy in neuroendocrine carcinoma of the fallopian tube.

Authors:  Anitha Raghunath; Grazyna Adamus; Diane C Bodurka; Jinsong Liu; Jade S Schiffman
Journal:  J Neuroophthalmol       Date:  2010-09       Impact factor: 3.042

Review 2.  Primary fallopian tube cancer: a review of the literature.

Authors:  A C Hellström
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

Review 3.  The oviduct and ovarian cancer: causality, clinical implications, and "targeted prevention".

Authors:  Christopher P Crum; Frank D McKeon; Wa Xian
Journal:  Clin Obstet Gynecol       Date:  2012-03       Impact factor: 2.190

4.  Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma.

Authors:  Ernst Lengyel; Saroj Fleming; Kelsey A McEwen; Anthony Montag; Sarah M Temkin
Journal:  Gynecol Oncol       Date:  2012-12-10       Impact factor: 5.482

Review 5.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

Review 6.  Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

Authors:  Christopher P Crum; Ronny Drapkin; David Kindelberger; Fabiola Medeiros; Alexander Miron; Yonghee Lee
Journal:  Clin Med Res       Date:  2007-03

7.  Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004.

Authors:  Marc T Goodman; Yurii B Shvetsov
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

8.  Primary Fallopian Tube Clear Cell Adenocarcinoma in Pregnancy: Case Presentation and Review of the Literature.

Authors:  Mohammed Malak; Stephanie Klam
Journal:  Case Rep Obstet Gynecol       Date:  2015-05-21

9.  Port-site metastasis as a primary complication following diagnostic laparoscopy of fallopian tube carcinoma: A case report.

Authors:  Yan Chen; Chen Ling; Ce Bian
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

10.  Developing and validating a novel nomogram used a competing-risks model for predicting the prognosis of primary fallopian tube carcinoma: a retrospective study based on the SEER database.

Authors:  Chengzhuo Li; Junyuan Li; Qiao Huang; Xiaojie Feng; Fanfan Zhao; Fengshuo Xu; Didi Han; Jun Lyu
Journal:  Ann Transl Med       Date:  2021-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.